Table 4

The performance of ACR-997 criteria, SLICC-2012 criteria, EULAR/ACR-2019 criteria and SLERPI after excluding patients with pSS and UCTD from the control group

Sensitivity (95% CI), %Specificity (95% CI),%Accuracy (95% CI),%
ACR-99782.1 (77.7, 86.0)98.0 (95.7, 99.3)89.4 (87.0, 91.7)
SLICC-201298.0 (95.9, 99.2)95.3 (92.2, 97.4)96.8 (95.4, 98.1)
EULAR/ACR-201997.4 (95.2, 98.8)93.9 (90.6, 96.4)95.8 (94.3, 97.4)
SLERPI98.3 (96.3, 99.4)94.3 (91.0, 96.6)96.5 (95.0, 97.9)
  • ACR, American College of Rheumatology; EULAR, European League Against Rheumatism; pSS, primary Sjogren’s syndrome; SLERPI, Systemic Lupus Erythematosus Risk Probability Index; SLICC, Systemic Lupus International Collaborating Clinics; UCTD, undifferentiated connective tissue disease.